Rating, from 69 to 74. Please watch the video at Investors.com - How To Find The Best IPO Stocks IBD's unique rating tracks ...

Henry Schein's market leadership and strategic acquisitions across various healthcare segments make it a solid investment, ...

We continued to make progress on our 2022 to 2024 BOLD+1 Strategic Plan which we recently ... Chairman of the Board and Chief Executive Officer of Henry Schein (HSIC). “We have confidence ...

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today repor ...

Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical ...

Revenue: US$12.7b (up 2.7% from FY 2023). Net income: US$390.0m (down 6.2% from FY 2023). Profit margin: 3.1% (down from 3.4% ...

Henry Schein (HSIC) came out with quarterly earnings of $1.19 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.66 per share a year ago. These figures are ...

NasdaqGS:HSIC Earnings and Revenue History March 5th 2025 The Impact Of Unusual Items On Profit. For anyone who wants to understand Henry Schein's profit beyond the statutory numb ...

Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the ...

Henry Schein Q4 sales grew 5.8% to $3.19 billion, missing estimates. The company was restructured into three segments.